- Cyclophosphamide 750 mg/m(2) IV day 1
- Doxorubicin 50 mg/m(2) IV day 1
- Vincristine 1.4 mg/m(2) IV day 1
- Prednisone 40 mg/m(2) PO for 5 days
- Rituximab 375 mg/m(2)IVI administered the same day as CHOP
Feugier P et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.J Clin Oncol. 2005 Jun 20;23(18):4117-26. Epub 2005 May 2.
Coiffier B et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002 Jan 24;346(4):235-42
Vose JM et al. Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2001 Jan 15;19(2):389-97.
MINT(MABTHERA International Trial Group) study, young patients with low and low intermediate risk based on IPI
Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition).Vol 22, No 14S (July 15 Supplement), 2004: 6500